We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
-5.87%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.11B
AUM Growth
-$636M
Cap. Flow
-$355M
Cap. Flow %
-11.42%
Top 10 Hldgs %
18.55%
Holding
435
New
67
Increased
62
Reduced
121
Closed
71

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$28.9M
2
CVS icon
CVS Health
CVS
+$27.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$25M
4
UNH icon
UnitedHealth
UNH
+$20.4M
5
CRM icon
Salesforce
CRM
+$18.8M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$43.8M
2
EWJ icon
iShares MSCI Japan ETF
EWJ
+$42.6M
3
KO icon
Coca-Cola
KO
+$40M
4
ILMN icon
Illumina
ILMN
+$31.6M
5
HAIN icon
Hain Celestial
HAIN
+$28.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 17.53%
3 Consumer Discretionary 16.73%
4 Industrials 11.77%
5 Energy 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYNO
426
DELISTED
Cynosure, Inc. Class A
CYNO
-279,175
Closed -$10.8M
SAAS
427
DELISTED
inContact, Inc.
SAAS
-913,279
Closed -$9.01M
BLOX
428
DELISTED
Infoblox Inc
BLOX
-486,375
Closed -$12.7M
SUNE
429
DELISTED
SUNEDISON, INC COM
SUNE
-160,175
Closed -$4.79M
MW
430
DELISTED
THE MENS WAREHOUSE INC
MW
-207,730
Closed -$13.3M
RYL
431
DELISTED
RYLAND GROUP INC
RYL
-106,300
Closed -$4.93M
RKT
432
DELISTED
ROCK-TENN COMPANY CL-A
RKT
-50,275
Closed -$3.03M
WLL
433
DELISTED
Whiting Petroleum Corporation
WLL
-723
Closed -$7.29M
CY
434
DELISTED
Cypress Semiconductor
CY
-670,050
Closed -$7.88M
AGN
435
DELISTED
Allergan Inc
AGN
-441
Closed -$134K

Similar funds

Castleark Management's Q3 2015 Portfolio in Review

As of Q3 2015, Castleark Management held 435 positions worth $3.11B, down 17% from $3.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Castleark Management withdrew a net $355M in Q3 2015, closing 71 positions and reducing 121 holdings. Its most notable exit was Aptiv, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Bristol-Myers Squibb worth $23.3M.

  • Castleark Management's largest Q3 2015 buy was Bristol-Myers Squibb: 393,310 shares worth $23.3M.
  • Castleark Management added most to Ulta Beauty in Q3 2015, an estimated $28.9M increase.
  • Castleark Management's biggest Q3 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $42.6M.
  • Castleark Management fully exited Aptiv in Q3 2015, selling an estimated $43.8M.
  • Castleark Management's ten largest holdings make up 19% of its $3.11B portfolio in Q3 2015.
  • Castleark Management opened 67 new positions and closed 71 in Q3 2015.
  • Castleark Management's portfolio value fell 17% quarter-over-quarter to $3.11B.

Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.